Increased incidence of chemoport-related thrombosis in patients with colorectal cancer receiving bevacizumab: A single-institutional experience

OBJECTIVE: Chemoport-related thrombosis (CRT) is a serious complication that causes morbidities and interrupts administration of intravenous cancer therapy. We investigated the incidence and risk of CRT in colorectal cancer (CRC) patients treated with bevacizumab (BEV). METHODS: We retrospectively r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jwa Hoon, Kim, Jeong Eun, Hong, Yong Sang, Kim, Sun Young, Kim, Kyu-pyo, Choi, Ki Eun, Shin, Ji Hoon, Kim, Tae Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129570/
https://www.ncbi.nlm.nih.gov/pubmed/30210226
http://dx.doi.org/10.21147/j.issn.1000-9604.2018.04.09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129570/
https://www.ncbi.nlm.nih.gov/pubmed/30210226
http://dx.doi.org/10.21147/j.issn.1000-9604.2018.04.09

Ejemplares similares